Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox)

Ophthalmic Plastic and Reconstructive Surgery

Volumn 30, Issue 3, 2014, Pages 246-250

  Couch, Steven M ^a   Chundury, Rao V ^c   Holds, John B ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b Ophthalmic Plastic and Cosmetic Inc   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BELL PALSY; CLINICAL ARTICLE; FACIAL CLINIMETRIC EVALUATION SCALE; FACIAL NERVE SYNKINESIS; FEMALE; FOLLOW UP; HERPES ZOSTER OTICUS; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROMA; OUTCOME ASSESSMENT; PATIENT COMFORT; PRIORITY JOURNAL; SOCIAL INTERACTION; STATUS POSTACOUSTIC NEUROMA; SUNNYBROOK FACIAL GRADING SYSTEM; SYNKINESIS;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; FACIAL MUSCLES; FACIAL NERVE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84900548166     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000086     Document Type: Article

References (16)

1. Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg 2008;24: 242-9.
2. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;549: 4-30.
3. Baker RS, Stava MW, Nelson KR, et al. Aberrant reinnervation of facial musculature in a subhuman primate: a correlative analysis of eyelid kinematics, muscle synkinesis, and motoneuron localization. Neurology 1994;44: 2165-73.
4. Yamamoto E, Nishimura H, Hirono Y. Occurrence of sequelae in Bell's palsy. Acta Otolaryngol Suppl 1988;446: 93-6.
5. Maeyama H, Aoyagi M, Tojima H, et al. Electrophysiological study on the pathology of synkinesis after facial nerve paralysis. Acta Otolaryngol Suppl 1994;511: 161-4.
6. Celik M, Forta H, Vural C. The development of synkinesis after facial nerve paralysis. Eur Neurol 2000;43: 147-51.
7. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope 1996;106(12 Pt 1): 1491-6.
8. Filipo R, Spahiu I, Covelli E, et al. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 2012;122: 266-70.
9. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Eur Arch Otorhinolaryngol 1994;S180-S181.
10. Kayhan FT, Zurakowski D, Rauch SD. Toronto facial grading system: interobserver reliability. Otolaryngol Head Neck Surg 2000;122: 212-5.
11. Kanerva M, Poussa T, Pitkäranta A. Sunnybrook and House- Brackmann Facial Grading Systems: intrarater repeatability and interrater agreement. Otolaryngol Head Neck Surg 2006;135: 865-71.
12. Kahn JB, Gliklich RE, Boyev KP, et al. Validation of a patient- graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope 2001;111: 387-98.
13. Kanaya K, Ushio M, Kondo K, et al. Recovery of facial movement and facial synkinesis in Bell's palsy patients. Otol Neurotol 2009;30: 640-4.
14. Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci 1996;21: 15-20.
15. Roggenkämper P, Laskawi R, Damenz W, et al. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol 1994;86: 395-402.
16. Toffola ED, Furini F, Redaelli C, et al. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010;32: 1414-8.